Mitotherapy in Alzheimer’s and Parkinson’s diseases: A systematic review of preclinical studies
Abstract Background Alzheimer’s disease (AD) and Parkinson’s disease (PD) are prevalent neurodegenerative disorders and strongly affect both the patients’ lives and their caregivers. Strategy to improve and restore mitochondrial function, as well as to treat mitochondria-associated diseases, as obse...
Saved in:
| Main Authors: | Aynur Modiri, Leila Hosseini, Nasrin Abolhasanpour, Hosein Azizi, Reza Naghdi Sadeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04241-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer
by: Yun Wei, et al.
Published: (2024-12-01) -
A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models
by: Musaab Abdulrazzaq Qader, et al.
Published: (2025-03-01) -
CNS Mitochondria‐Derived Vesicle in Blood: Potential Biomarkers for Brain Mitochondria Dysfunction
by: Qi Liu, et al.
Published: (2025-07-01) -
Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer’s Disease: A Narrative Review
by: Erica Spina, et al.
Published: (2025-02-01) -
Correction of mitochondrial dysfunction with trimethoxy-substituted monocarbonyl curcumin analogues in experimental Alzheimer’s disease
by: D. I. Pozdnyakov, et al.
Published: (2024-01-01)